Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 KO Manufacturing
Filings indexed 553 across all filing types
Latest filing 2024-02-20 Report Publication Anno…
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the event, and mentions that the presentation materials are available on the KRX website. Since this is an announcement of an event/presentation rather than the presentation deck itself, and it is under 5,000 characters, it falls under the Report Publication Announcement (RPA) category as it notifies the public of the availability of IR materials.
2024-02-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from HLB regarding a significant change (over 30%) in revenue or profit/loss structure compared to the previous fiscal year. This is a standard financial disclosure required by stock exchanges (often referred to as a 'Material Change in Financial Results' filing). Since it provides the initial announcement of financial performance highlights rather than a full annual report or a transcript, it falls under the Earnings Release (ER) category. FY 2023
2024-02-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement (865 characters) regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, and purpose of the meeting. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation material itself, and it does not fit into specific categories like 'Call Transcript' or 'Investor Presentation', it is classified as a Regulatory Filing (RNS) as it serves as a formal notice of a corporate event.
2024-02-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the major shareholder (Jin Yang-gon) and related parties of HLB. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-02-06 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). This falls under the category of changes in board composition or management, which is classified as MANG.
2024-02-02 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding the scheduling and details of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, but it is not the presentation material itself. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Report Publication Announcement (RPA) or a general regulatory filing. Given the specific nature of announcing an IR event, RPA is the most appropriate classification.
2024-01-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.